• High-yield continuous lentiviral vector bioprocessing through perfusion intensification and integrated cold chain affinity capture

    Ar-lein

    Perfusion intensification, cold harvest stabilization, and inline affinity capture together can more than double lentiviral vector (LVV) recovery while removing steps from the process. This session presents a continuous LVV workflow that reached around 12 × 10⁶ viable cells/mL before transfection and delivered roughly 16-fold higher cumulative transduction units over 3 days through cold harvest handling. Keen Chung, Technical Lead…

  • Delivering confidence in precision medicine: strategies for potency, safety, and long-term success

    Ar-lein

    This webinar explores the scientific and analytical capabilities required to support precision medicine programs across advanced modalities such as cell and gene therapy, and complex therapeutic areas, including oncology and neurology. Join an expert panel as they explore key considerations in potency assessment, safety monitoring and evidence generation, with a focus on building integrated strategies that support development from early…

  • Transitioning to serum-free T cell manufacturing: process considerations and cross-platform scale-up data

    Ar-lein

    Serum is one of the largest sources of variability in T cell manufacturing, driving lot-to-lot inconsistency, sourcing constraints, and contamination risk. This data-led session shows you how a chemically defined, serum-free workflow removes that dependency, so you can build more reproducible processes from early development through clinical scale. Chengkang Zhang will walk through experimental data on the impact of serum…